Skip to main content
Gabriella Horvath, MD, Internal Medicine, Morgantown, WV

Gabriella Gizella Horvath MD


HHP Internal Medicine Associates , PLLC

Join to View Full Profile
  • 3132 Collins Ferry RdMorgantown, WV 26505

  • Phone+1 304-598-2442

  • Fax+1 304-598-2700

Dr. Horvath is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Gabriella Horvath, MD, is an internal medicine specialist based in Morgantown, WV. She completed her medical education at Albert Szent-Gyorgi Medical University in 1982 and her residency in internal medicine at West Virginia University from 1995 to 1998. Dr. Horvath has several notable publications, including work on autonomic dysfunction and type 1 diabetes, with citations indicating recognition in the field. She has also been recognized with multiple CMS Meaningful Use Stage 1 and Stage 2 Certifications through Cerner Corporation from 2012 to 2017.

Education & Training

  • West Virginia University
    West Virginia UniversityResidency, Internal Medicine, 1995 - 1998
  • Albert Szent - Gyorgi Medical University
    Albert Szent - Gyorgi Medical UniversityClass of 1982

Certifications & Licensure

  • WV State Medical License
    WV State Medical License 1998 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Powerworks, Cerner Healthe and Cerner Patient Portal, Cerner Corporation, 2012, 2014-2017
  • CMS Meaningful Use Stage 2 Certification PowerChart (CQM), Cerner Corporation, 2012, 2014-2017
  • CMS Meaningful Use Stage 1 Certification Cerner Patient Portal and Powerchart, Cerner Corporation, 2012, 2014-2017

Publications & Presentations

PubMed

Press Mentions

  • Correction to: De Novo Variants in SNAP25 Cause an Early-Onset Developmental and Epileptic Encephalopathy
    Correction to: De Novo Variants in SNAP25 Cause an Early-Onset Developmental and Epileptic EncephalopathyMarch 8th, 2021
  • De Novo Variants in SNAP25 Cause an Early-Onset Developmental and Epileptic Encephalopathy
    De Novo Variants in SNAP25 Cause an Early-Onset Developmental and Epileptic EncephalopathyDecember 10th, 2020
  • Correction to: Consensus Guideline for the Diagnosis and Treatment of Tetrahydrobiopterin (BH4) Deficiencies
    Correction to: Consensus Guideline for the Diagnosis and Treatment of Tetrahydrobiopterin (BH4) DeficienciesAugust 5th, 2020

Research History

  • Research associateWest Virginia University School of Medicine, dept of endocrinology

Other Languages

  • Hungarian

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: